| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |